{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:47:35Z","timestamp":1785844055951,"version":"3.56.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020473","name":"Ministry of Research Technology and Higher Education of the Republic of Indonesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["NKB-763\/UN2.RST\/HKP.05.00\/2022"],"award-info":[{"award-number":["NKB-763\/UN2.RST\/HKP.05.00\/2022"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.repbio.2026.101210","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:36:12Z","timestamp":1773776172000},"page":"101210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in progesterone receptor-targeted therapy for uterine fibroids: A systematic review of synthetic and natural modulators"],"prefix":"10.1016","volume":"26","author":[{"given":"Hendike Yuniar","family":"Purnamasari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Rahmasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2378-1921","authenticated-orcid":false,"given":"Aini","family":"Gusmira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Leonard","family":"A M Sitorus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Mun\u2019im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Elya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0170-9885","authenticated-orcid":false,"given":"Heri","family":"Setiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-7446","authenticated-orcid":false,"given":"Apriliana Cahya","family":"Khayrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repbio.2026.101210_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Women\u2019s Health"},{"key":"10.1016\/j.repbio.2026.101210_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2018.10.012","article-title":"Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study","volume":"111","author":"Bradley","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2026.101210_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-030-38474-6_3","article-title":"Role of hormones in common benign uterine lesions: endometrial polyps, leiomyomas, and adenomyosis","volume":"1242","author":"Kossa\u00ef","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.repbio.2026.101210_bib4","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.5114\/aoms\/171786","article-title":"Global epidemiological characteristics of uterine fibroids","volume":"19","author":"Li","year":"2023","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.repbio.2026.101210_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53467-w","article-title":"EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model","volume":"9","author":"Nair","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.repbio.2026.101210_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149631","article-title":"Medical therapies for uterine fibroids \u2013 a systematic review and network meta-analysis of randomised controlled trials","volume":"11","author":"Gurusamy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.repbio.2026.101210_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.12.206","article-title":"The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids","volume":"218","author":"Singh","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.repbio.2026.101210_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa012","article-title":"Selective progesterone receptor modulators\u2014mechanisms and therapeutic utility","volume":"41","author":"Islam","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.repbio.2026.101210_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0035-1558451","article-title":"Uterine leiomyoma stem cells: linking progesterone to growth","volume":"33","author":"Bulun","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.repbio.2026.101210_bib10","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"T. Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.repbio.2026.101210_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repbio.2026.101210_bib12","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2026.101210_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14728222.2016.1180368","article-title":"Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies","volume":"20","author":"Wagenfeld","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.repbio.2026.101210_bib14","article-title":"Antiprogestins in gynecological diseases","volume":"149","author":"Goyeneche","year":"2014","journal-title":"Reproduction"},{"key":"10.1016\/j.repbio.2026.101210_bib15","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/bcp.14708","article-title":"Risk\u2013efficacy balance of ulipristal acetate compared to surgical alternatives","volume":"87","author":"Middelkoop","year":"2021","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.repbio.2026.101210_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejogrb.2020.06.064","article-title":"Suspension of ulipristal acetate for uterine fibroids during ongoing EMA\u2019s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!","volume":"252","author":"Rozenberg","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.repbio.2026.101210_bib17","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Ulipristal acetate 5 mg (Esmya): further restrictions due to risk of serious liver injury. London: 2021."},{"key":"10.1016\/j.repbio.2026.101210_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/TCRM.S273358","article-title":"Hepatic safety considerations in the use of ulipristal acetate for symptomatic uterine fibroids","volume":"21","author":"Semmler","year":"2025","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.repbio.2026.101210_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12958-021-00790-5","article-title":"5-aza-2\u2032-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt\/\u03b2-catenin pathway in human uterine leiomyomas","volume":"19","author":"Carbajo-Garc\u00eda","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1210\/me.2012-1328","article-title":"A New Strategy for selective targeting of progesterone receptor with passive antagonists","volume":"27","author":"Khan","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12672-016-0255-4","article-title":"Anti-tumoral effects of anti-progestins in a patient-derived breast cancer xenograft model","volume":"7","author":"Esber","year":"2016","journal-title":"Horm Cancer"},{"key":"10.1016\/j.repbio.2026.101210_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1248\/cpb.c19-00094","article-title":"Design, synthesis and biological evaluation of novel nonsteroidal progesterone receptor antagonists based on phenylamino-1,3,5-triazine scaffold","volume":"67","author":"Kaitoh","year":"2019","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.repbio.2026.101210_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/molecules29071587","article-title":"Design, Synthesis, and Evaluation of B-(Trifluoromethyl)phenyl Phosphine\u2013Borane Derivatives as Novel Progesterone Receptor Antagonists","volume":"29","author":"Miyajima","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.repbio.2026.101210_bib24","first-page":"1","article-title":"EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model","volume":"9","author":"Nair","year":"2019","journal-title":"Sci Rep 2019"},{"key":"10.1016\/j.repbio.2026.101210_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1201547","article-title":"Next step in the development of mesoprogestins: the preclinical profile of EC313","volume":"14","author":"B\u0142aszczak-\u015awi\u0105tkiewicz","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jsbmb.2010.05.005","article-title":"Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium","volume":"122","author":"Catherino","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.repbio.2026.101210_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acsmedchemlett.6b00184","article-title":"Development of N-(4-Phenoxyphenyl)benzenesulfonamide derivatives as novel nonsteroidal progesterone receptor antagonists","volume":"7","author":"Yamada","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.repbio.2026.101210_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acsmedchemlett.8b00058","article-title":"Novel nonsteroidal progesterone receptor (PR) antagonists with a phenanthridinone skeleton","volume":"9","author":"Nishiyama","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.repbio.2026.101210_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1248\/cpb.c17-00544","article-title":"Novel non-steroidal progesterone receptor ligands based on m-carborane containing a secondary alcohol: effect of chirality on ligand activity","volume":"65","author":"Mori","year":"2017","journal-title":"Chem Pharm Bull"},{"issue":"14","key":"10.1016\/j.repbio.2026.101210_bib30","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.3390\/cancers14184424","article-title":"Astragaloside IV inhibits the proliferation of human uterine leiomyomas by targeting IDO1","volume":"14","author":"Qiu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.repbio.2026.101210_bib31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2015.01.010","article-title":"Berberine inhibits the proliferation of human uterine leiomyoma cells","volume":"103","author":"Wu","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2026.101210_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12672-020-00382-6","article-title":"Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors","volume":"11","author":"Austin","year":"2020","journal-title":"Horm Cancer"},{"key":"10.1016\/j.repbio.2026.101210_bib33","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2008.03.045","article-title":"Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression","volume":"91","author":"Malik","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2026.101210_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110751","article-title":"Deoxyelephantopin, a novel naturally occurring phytochemical impairs growth, induces G2\/M arrest, ROS-mediated apoptosis and modulates lncRNA expression against uterine leiomyoma","volume":"131","author":"Pandey","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.repbio.2026.101210_bib35","first-page":"1","article-title":"Fisetin induces apoptosis in uterine leiomyomas through multiple pathways","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.repbio.2026.101210_bib36","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/acs.jnatprod.8b00131","article-title":"Irilone from Red Clover (Trifolium pratense) Potentiates Progesterone Signaling","volume":"81","author":"Lee","year":"2018","journal-title":"J Nat Prod"},{"issue":"24","key":"10.1016\/j.repbio.2026.101210_bib37","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/molecules24081556","article-title":"Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf.) Hull Extract and Active Compounds Inhibit Proliferation of Primary Human Leiomyoma Cells and Protect against Sexual Hormone-Induced Mice Smooth Muscle Hyperproliferation","volume":"24","author":"Lin","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.repbio.2026.101210_bib38","doi-asserted-by":"crossref","first-page":"23575","DOI":"10.18632\/oncotarget.15333","article-title":"An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells","volume":"8","author":"Islam","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.repbio.2026.101210_bib39","first-page":"341","article-title":"The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments","volume":"4","author":"Bai","year":"2023","journal-title":"F S Sci"},{"key":"10.1016\/j.repbio.2026.101210_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/njecp.njecp_40_21","article-title":"Antifibrotic Potential of Tetracarpidium conophorum (African Walnut) Leaves Extract on Diethylstilbestrol-Induced Rat Model of Uterine Fibroid","volume":"9","author":"Oyinloye","year":"2021","journal-title":"Niger J Exp Clin Biosci"},{"key":"10.1016\/j.repbio.2026.101210_bib41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0254-6272(13)60084-9","article-title":"Effect of Lichong Decoction on expression of IGF-I and proliferating cell nuclear antigen mRNA in rat model of uterine leiomyoma","volume":"32","author":"Li","year":"2012","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.repbio.2026.101210_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01105","article-title":"Gyejibongnyeong-hwan (gui zhi fu ling wan) ameliorates human uterine myomas via apoptosis","volume":"10","author":"Lee","year":"2019","journal-title":"Front Pharm"},{"key":"10.1016\/j.repbio.2026.101210_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.dcmed.2021.12.006","article-title":"Effects of Fuke Qianjin Formula on hormones and their receptors and metabonomics study in uterine fibroids model rats","volume":"4","author":"Yamei","year":"2021","journal-title":"Digit Chin Med"},{"key":"10.1016\/j.repbio.2026.101210_bib44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.repbio.2026.101210_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pr Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.repbio.2026.101210_bib46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0030-1251482","article-title":"Receptor Tyrosine Kinases and Their Hormonal Regulation in Uterine Leiomyoma","volume":"28","author":"Yu","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.repbio.2026.101210_bib47","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"2017","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2026.101210_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(93)90135-6","article-title":"Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas","volume":"169","author":"Bethea","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.repbio.2026.101210_bib49","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/humrep\/14.11.2844","article-title":"Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy","volume":"14","author":"Nisolle","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2026.101210_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.advms.2024.01.001","article-title":"Progesterone signaling in uterine leiomyoma biology: Implications for potential targeted therapy","volume":"69","author":"Szucio","year":"2024","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.repbio.2026.101210_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2011.09.016","article-title":"Progesterone receptors, their isoforms and progesterone regulated transcription","volume":"357","author":"Jacobsen","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tem.2017.05.006","article-title":"Progesterone-mediated non-classical signaling","volume":"28","author":"Garg","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.repbio.2026.101210_bib53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.repbio.2026.101210_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/biolre\/iox094","article-title":"Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids","volume":"97","author":"Ali","year":"2017","journal-title":"Biol Reprod"},{"key":"10.1016\/j.repbio.2026.101210_bib55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2026.101210_bib56","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1016\/S0021-9258(18)41805-4","article-title":"Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation","volume":"267","author":"Allan","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.repbio.2026.101210_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(01)00743-2","article-title":"CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914","volume":"188","author":"Attardi","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib58","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/annonc\/mdt216","article-title":"Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer","volume":"24","author":"Jonat","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.repbio.2026.101210_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.09.032","article-title":"Inverse agonism or neutral antagonism at G-protein coupled receptors: A medicinal chemistry challenge worth pursuing?","volume":"553","author":"Greasley","year":"2006","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.repbio.2026.101210_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3211","article-title":"Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression","volume":"14","author":"Knutson","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.repbio.2026.101210_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/ERC-08-0281","article-title":"Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models","volume":"16","author":"Dressing","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.repbio.2026.101210_bib62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1933719117746764","article-title":"Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone","volume":"25","author":"Kannan","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.repbio.2026.101210_bib63","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.1197454","article-title":"The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2","volume":"331","author":"Li","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.repbio.2026.101210_bib64","doi-asserted-by":"crossref","first-page":"T15","DOI":"10.1530\/JME-19-0238","article-title":"90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies","volume":"65","author":"Critchley","year":"2020","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.repbio.2026.101210_bib65","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/cmdc.201800487","article-title":"Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies","volume":"13","author":"M\u00f6ller","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.repbio.2026.101210_bib66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ogrm.2014.05.007","article-title":"Uterine fibroids and Ulipristal","volume":"24","author":"Talaulikar","year":"2014","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"10.1016\/j.repbio.2026.101210_bib67","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1210\/jc.2002-020429","article-title":"Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium","volume":"87","author":"Hapangama","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2026.101210_bib68","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/humrep\/del035","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGF\u03b23 and their receptors in cultured uterine leiomyoma cells","volume":"21","author":"Wang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2026.101210_bib69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2003.12.004","article-title":"vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone","volume":"88","author":"Attardi","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.repbio.2026.101210_bib70","first-page":"540","article-title":"Differential regulatory effect of progesterone on the proliferation and apoptosis of uterine leiomyoma tissue explants and primary leiomyoma cell cultures","volume":"25","author":"Voronin","year":"2021","journal-title":"J Bras Reprod Assist"},{"key":"10.1016\/j.repbio.2026.101210_bib71","first-page":"111","article-title":"Proliferative Activity of Human Uterine Leiomyoma Cells as Measured by Automatic Image Analysis","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.repbio.2026.101210_bib72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.repbio.2026.101210_bib73","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jcem-9-12-1273","article-title":"The Progesterone Therapy Of Human Uterine Leiomyomas","volume":"9","author":"SEGALOFF","year":"1949","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2026.101210_bib74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Ohara","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.repbio.2026.101210_bib75","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.maturitas.2014.04.011","article-title":"Management of leiomyomas in perimenopausal women","volume":"78","author":"Ciarmela","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.repbio.2026.101210_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-022-01924-6","article-title":"Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma","volume":"22","author":"Tanioka","year":"2022","journal-title":"BMC Women\u2019s Health"},{"key":"10.1016\/j.repbio.2026.101210_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112435","article-title":"Role of transforming growth factor \u03b2 in uterine fibroid biology","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.repbio.2026.101210_bib78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.repbio.2026.101210_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119381","article-title":"Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis","volume":"1870","author":"Lu","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) Molecular Cell Research"},{"key":"10.1016\/j.repbio.2026.101210_bib80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/antiox12040807","article-title":"Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications","volume":"12","author":"AlAshqar","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.repbio.2026.101210_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17460441.2018.1417381","article-title":"Successes and failures of uterine leiomyoma drug discovery","volume":"13","author":"Ali","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"9","key":"10.1016\/j.repbio.2026.101210_bib82","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/jcm9051479","article-title":"The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids","volume":"9","author":"Ciebiera","year":"2020","journal-title":"J Clin Med"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X2600032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X2600032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:32:57Z","timestamp":1785843177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X2600032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1642431X2600032X"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2026.101210","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in progesterone receptor-targeted therapy for uterine fibroids: A systematic review of synthetic and natural modulators","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2026.101210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101210"}}